SGLT2 inhibitors improve outcomes in people with type 2 diabetes and chronic kidney disease

By Editor
12th June 2024
Chronic Kidney Disease, Pharmaceutical Pharmacy Research Type 2 diabetes
You can sign in with OneKey / OWA to view this content.

Comments (0)